{"id":947,"company":{"country":"US","currency":"USD","exchange":"NASDAQ NMS - GLOBAL MARKET","ipo":"2015-05-07","marketCap":824.586,"name":"Collegium Pharmaceutical Inc","phone":"17817133699.0","outstanding":34.73,"symbol":"COLL","website":"https://www.collegiumpharma.com/","industry":"Pharmaceuticals"},"price":25.2825,"year":2023,"month":11,"day":18,"weekday":"Saturday","title":"Historical Price-to-Earnings (P/E) Ratio Trends of Collegium Pharmaceutical Inc Stock","date":"2023-11-18","url":"/posts/2023/11/18/COLL","content":[{"section":"Introduction","text":"The price-to-earnings (P/E) ratio is a commonly used valuation metric that compares a company's stock price to its earnings per share (EPS). It is an important indicator of market sentiment and investor expectations regarding a company's future profitability."},{"section":"Historical P/E Ratio Data","text":"Below is a summary of Collegium Pharmaceutical Inc's historical P/E ratio data:"},{"section":"Year","text":"P/E Ratio"},{"section":"2016","text":"N/A"},{"section":"2017","text":"64.56"},{"section":"2018","text":"40.87"},{"section":"2019","text":"18.02"},{"section":"2020","text":"25.51"},{"section":"2021","text":"42.69"},{"section":"Significance for Investors","text":"The analysis of Collegium Pharmaceutical Inc's historical P/E ratio trends can provide the following insights for investors:"},{"section":"1. Valuation","text":"By comparing the current P/E ratio with historical averages, investors can assess whether the stock is overvalued or undervalued. Higher P/E ratios indicate higher expectations for future earnings growth, while lower P/E ratios may suggest undervaluation."},{"section":"2. Market Sentiment","text":"P/E ratio trends can reflect the market's sentiment towards a company. Increasing P/E ratios may indicate positive market sentiment, while decreasing ratios may suggest a lack of confidence in the company's future earnings prospects."},{"section":"3. Long-term Performance","text":"Studying P/E ratio trends over multiple years can provide insights into a company's long-term performance. Consistently high or increasing P/E ratios may indicate sustained growth and profitability, while fluctuating or decreasing ratios may suggest volatility or challenges in the business."}],"tags":["CrossOver55","Long","Pharmaceuticals"],"news":[{"category":"company","date":1699992528,"headline":"12 Cheap NASDAQ Stocks To Buy","id":123870795,"image":"https://s.yimg.com/ny/api/res/1.2/2Pcty5znqNLtDgUPm4GWLw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://media.zenfs.com/en/insidermonkey.com/edbdd58d96bb65bbb9d02be6765bef63","symbol":"COLL","publisher":"Yahoo","summary":"In this piece, we will take a look at the 12 cheap NASDAQ stocks to buy. To skip our overview of one of the world’s largest stock exchanges and some recent financial news, read 5 Cheap NASDAQ Stocks To Buy. Stocks markets have been taking a hammering over the past couple of years amid a […]","url":"https://finance.yahoo.com/news/12-cheap-nasdaq-stocks-buy-200848469.html"},{"category":"company","date":1699534800,"headline":"Collegium Announces $25 Million Accelerated Share Repurchase Program","id":123754130,"image":"https://s.yimg.com/ny/api/res/1.2/zIY_BvwgmfSVd4crOMeKqg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD00MDA-/https://media.zenfs.com/en/globenewswire.com/c8b3a095e02b16a6ec90a20beeaa5ff6","symbol":"COLL","publisher":"Yahoo","summary":"STOUGHTON, Mass., Nov. 09, 2023 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading, diversified specialty pharmaceutical company committed to improving the lives of people living with serious medical conditions, today announced that it has entered into an Accelerated Share Repurchase (\"ASR\") agreement with Jefferies LLC to repurchase $25 million of the Company’s common stock. Collegium will execute the ASR as part of the $100 million share repurchase program authorized","url":"https://finance.yahoo.com/news/collegium-announces-25-million-accelerated-130000622.html"},{"category":"company","date":1699529319,"headline":"Should You Be Worried About Collegium Pharmaceutical, Inc.'s (NASDAQ:COLL) 5.0% Return On Equity?","id":123754131,"image":"https://media.zenfs.com/en/simply_wall_st__316/fd5474a7eee0c5f442903b68fe63249b","symbol":"COLL","publisher":"Yahoo","summary":"One of the best investments we can make is in our own knowledge and skill set. With that in mind, this article will...","url":"https://finance.yahoo.com/news/worried-collegium-pharmaceutical-inc-nasdaq-112839915.html"},{"category":"company","date":1699515840,"headline":"Collegium Pharmaceutical announces $25M accelerated share repurchase deal","id":123761349,"image":"","symbol":"COLL","publisher":"Seeking Alpha","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3204100698"},{"category":"company","date":1699515000,"headline":"Collegium Pharmaceutical announces $25M accelerated share repurchase program","id":123761350,"image":"","symbol":"COLL","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3204082866"},{"category":"company","date":1699455192,"headline":"Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Q3 2023 Earnings Call Transcript","id":123721998,"image":"https://s.yimg.com/ny/api/res/1.2/DMZVLG_PbNuL7ncciXyYsQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02NzM-/https://media.zenfs.com/en/insidermonkey.com/8bb973205da2dbdf2fe412d25bbfbcd3","symbol":"COLL","publisher":"Yahoo","summary":"Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Q3 2023 Earnings Call Transcript November 7, 2023 Collegium Pharmaceutical, Inc. misses on earnings expectations. Reported EPS is $0.53 EPS, expectations were $1.24. Operator: Greetings, and welcome to Collegium Pharmaceuticals Third Quarter 2023 Earnings Conference Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow […]","url":"https://finance.yahoo.com/news/collegium-pharmaceutical-inc-nasdaq-coll-145312372.html"},{"category":"company","date":1699453828,"headline":"Here's What Key Metrics Tell Us About Collegium Pharmaceutical (COLL) Q3 Earnings","id":123754134,"image":"https://media.zenfs.com/en/zacks.com/26a86d59f0e8f1e82a35a92ae5684cd9","symbol":"COLL","publisher":"Yahoo","summary":"While the top- and bottom-line numbers for Collegium Pharmaceutical (COLL) give a sense of how the business performed in the quarter ended September 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.","url":"https://finance.yahoo.com/news/heres-key-metrics-tell-us-143028849.html"},{"category":"company","date":1699448400,"headline":"Collegium to Participate in Upcoming Investor Conferences","id":123719430,"image":"https://s.yimg.com/ny/api/res/1.2/zIY_BvwgmfSVd4crOMeKqg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD00MDA-/https://media.zenfs.com/en/globenewswire.com/c8b3a095e02b16a6ec90a20beeaa5ff6","symbol":"COLL","publisher":"Yahoo","summary":"STOUGHTON, Mass., Nov. 08, 2023 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading, diversified specialty pharmaceutical company committed to improving the lives of people living with serious medical conditions, today announced that management will participate in the following investor conferences: Jefferies 14th Annual Global Healthcare ConferenceFireside Chat Date and Time: Tuesday, November 14, 2023, at 9:30 a.m. GMT Piper Sandler 35th Annual Healthcare ConferenceFir","url":"https://finance.yahoo.com/news/collegium-participate-upcoming-investor-conferences-130000342.html"},{"category":"company","date":1699432200,"headline":"Collegium Pharmaceutical (COLL) Gets a Buy from Truist Financial","id":123761351,"image":"","symbol":"COLL","publisher":"TipRanks","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3203310772"},{"category":"company","date":1699395313,"headline":"Collegium Pharmaceutical, Inc. (COLL) Q3 2023 Earnings Call Transcript","id":123708025,"image":"https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png","symbol":"COLL","publisher":"SeekingAlpha","summary":"Collegium Pharmaceutical, Inc. (NASDAQ:NASDAQ:COLL) Q3 2023 Earnings Conference Call November 7, 2023 4:30 PM ETCompany ParticipantsChristopher James - Vice...","url":"https://seekingalpha.com/article/4648904-collegium-pharmaceutical-inc-coll-q3-2023-earnings-call-transcript"},{"category":"company","date":1699390860,"headline":"Collegium Reports Third Quarter 2023 Financial Results","id":123716492,"image":"https://s.yimg.com/ny/api/res/1.2/zIY_BvwgmfSVd4crOMeKqg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD00MDA-/https://media.zenfs.com/en/globenewswire.com/c8b3a095e02b16a6ec90a20beeaa5ff6","symbol":"COLL","publisher":"Yahoo","summary":"– Q3’23 Net Revenue of $136.7 Million, Up 8% Year-over-Year – – Q3’23 GAAP Net Income of $20.6 Million vs. Q3’22 GAAP Net Income of $0.5 Million – – Record Q3’23 Adjusted EBITDA of $89.4 Million, Up 19% Year-over-Year – – Received Extension of Nucynta® Regulatory Exclusivity through July 2026 – – Board of Directors Authorized $25.0 Million Accelerated Share Repurchase Program – – Updated Full Year 2023 Guidance – – Conference Call Scheduled for Today at 4:30 p.m. ET – STOUGHTON, Mass., Nov. 07,","url":"https://finance.yahoo.com/news/collegium-reports-third-quarter-2023-210100418.html"},{"category":"company","date":1699375440,"headline":"Collegium Pharmaceutical: Q3 Earnings Snapshot","id":123740498,"image":"","symbol":"COLL","publisher":"Associated Press, The","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=tkmos4cgfi"},{"category":"company","date":1699327080,"headline":"Recap: Collegium Pharmaceutical Q3 Earnings","id":123740502,"image":"","symbol":"COLL","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3200392171"},{"category":"company","date":1699326660,"headline":"Collegium Pharmaceutical Non-GAAP EPS of $1.34 beats by $0.10, revenue of $136.7M misses by $2.84M","id":123740503,"image":"","symbol":"COLL","publisher":"Seeking Alpha","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3200376328"}]}